ALBT (Avalon Globocare) Insider Ownership : 59.02 % (As of Dec. 13, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Avalon Globocare Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Avalon Globocare's insider ownership is 59.02%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Avalon Globocare's Institutional Ownership is 1.53%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Avalon Globocare's Float Percentage Of Total Shares Outstanding is 62.77%.

Avalon Globocare Insider Ownership Historical Data

The historical data trend for Avalon Globocare's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avalon Globocare Insider Ownership Chart

Avalon Globocare Historical Data

The historical data trend for Avalon Globocare can be seen below:

	2022-03-31	2022-04-30	2022-05-31	2022-06-30	2022-07-31	2022-08-31	2022-09-30	2022-10-31	2022-11-30	2022-12-31
Insider Ownership	58.40	58.40	58.18	58.13	60.78	59.48	59.48	59.48	59.02	59.02

Avalon Globocare Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Avalon Globocare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Avalon Globocare Corp (NAS:ALBT) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

4400 Route 9 South, Suite 3100, Freehold, NJ, USA, 07728

Website

https://www.avalon-globocare.com

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Executives

Lourdes Felix	director	15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
W J Tauzin	director	901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508
Wenzhao Lu	director, 10 percent owner	C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Steven Andrew Sanders	director	431 EAST 20TH STREET, NEW YORK NY 10010
Yancen Lu	director	14009 SE 50TH STREET, BELLEVUE WA 98006
Stilley William B. Iii	director	1180 SEMINOLE TRAIL, SUITE 495, CHARLOTTESVILLE VA 22901
Tevi Troy	director	611 SOMERSWORTH WAY, SILVER SPRING MD 20902
Luisa Ingargiola	officer: Chief Financial Officer	4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
David Jin	director, officer: CEO and President	C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Yue Charles Li	director	C/O AVALON GLOBOCARE CORP., 4400 ROUTE 9 SOUTH, SUITE 3100, FREEHOLD NJ 07728
Meng Li	director, officer: Chief Operating Officer	C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Steven Philip Sukel	director	33 ALPINE DRIVE, MORGANVILLE NJ 07751